What’s Vulnerable › Vulnerabilities
CVE-2026-41360: OpenClaw < 2026.4.2 - Approval Integrity Bypass in pnpm dlx Local Script Binding
- Severity: medium (CVSS 6.7 v3.1)
- Exploited in the wild: not listed in CISA KEV
- EPSS: 0.1% probability of exploitation in the next 30 days
- Public exploit or detection template: none known
- Published: 2026-04-23 · updated 2026-06-17
- Weakness: CWE-367
Description
OpenClaw before 2026.4.2 contains an approval integrity vulnerability in pnpm dlx that fails to bind local script operands consistently with pnpm exec flows. Attackers can replace approved local scripts before execution without invalidating the approval plan, allowing execution of modified script contents.
Affected products
- OpenClaw: before 2026.4.2 — fixed in 2026.4.2
How to fix
Upgrade to a fixed version: OpenClaw 2026.4.2. Check the vendor advisory for mitigations.
References
- https://github.com/openclaw/openclaw/commit/176c059b05357df1bc09d4328a2380670859eeff
- https://github.com/openclaw/openclaw/security/advisories/GHSA-w6wx-jq6j-6mcj
- https://www.vulncheck.com/advisories/openclaw-approval-integrity-bypass-in-pnpm-dlx-local-script-binding
Get alerted when CVE-2026-41360 or the next vulnerability affects your stack